NEW YORK, Feb. 1 - Genaissance Pharmaceuticals and Biogen struck a deal to combine pharmacogenomic testing and drug development, the two companies said on Friday.
Already have a GenomeWeb or 360Dx account?Login Now.
American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.
A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.
Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.
In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.